NRS PHARMA LTD - Accounts

NRS PHARMA LTD
Contents Page
For the year ended 31 August 2025

Company information	1
Statement of financial position	2

NRS PHARMA LTD
Company Information
For the year ended 31 August 2025

Director	Naeem Rizwan SETH
Registered Number	15046511
Registered Office	OLD DOCKS HOUSE 90 WATERY LANE ASHTON-ON-RIBBLE PRESTON PR2 1AU
Accountants	Fiscal Umbrella Accountants Suite 2B Crystal House Luton LU11HS

1

NRS PHARMA LTD
Statement of Financial Position
As at 31 August 2025

	2025
	£	£
Current assets	1
Net current assets		1
Total assets less current liabilities		1
Net assets		1


Capital and reserves		1

NOTES TO THE ACCOUNTS

General Information

NRS PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 15046511, registration address OLD DOCKS HOUSE 90 WATERY LANE, ASHTON-ON-RIBBLE , PRESTON, PR2 1AU.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling which is the functional currency of the company.

2.	Average number of employees Average number of employees during the year was 1.

For the year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the director on 18 May 2026 and were signed by:

--------------------------------
Naeem Rizwan SETH
Director

2

Registered Number: 15046511
England and Wales
NRS PHARMA LTD

Unaudited Financial Statements

Period of accounts Start date: 01 September 2024 End date: 31 August 2025